Hypoxia and angiogenesis in rheumatic diseases;Hypoxie und Angiogenese in rheumatischen Erkrankungen

Zeitschrift fur Rheumatologie, Supplement

Volumn 62, Issue 2, 2003, Pages

  Distler, O ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Angiogenesis; HIF 1; Hypoxia; Rheumatoid arthritis; Systemic sclerosis

Indexed keywords

ANGIOGENIC FACTOR; ANGIOSTATIN; COLLAGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR; VASCULOTROPIN;

ANGIOGENESIS; BONE MARROW CELL; CAPILLARY; CONFERENCE PAPER; DIMERIZATION; HUMAN; HYPOXIA; INFLAMMATION; LABORATORY; PATHOGENESIS; PROTEIN EXPRESSION; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SKIN; SYSTEMIC SCLEROSIS;

ANGIOSTATIC PROTEINS; ANIMALS; ANOXIA; ARTHRITIS, RHEUMATOID; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; JOINTS; MICE; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; SCLERODERMA, SYSTEMIC; SKIN; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 1142297384     PISSN: 09418466     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249-257
2. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J (2000) Vascular-specific growth factors and blood vessel formation. Nature 407:242-248
3. Kung AL, Wang S, Klco JM, Kaelin WG, Livingston DM (2000) Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat Med 6:1335-1340
4. Hollander AP, Corke KP, Freemont AJ, Lewis CE (2001) Expression of hypoxia-inducible factor 1alpha by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. Arthritis Rheum 44:1540-1544
5. Giatromanolaki A, Sivridis E, Maltezos E et al (2003) Upregulated hypoxia inducible factor-1a and -2a pathway in rheumatoid arthritis and osteoarthri tis. Arthritis Res Ther 5:R193-R201
6. Cramer T, Yamanishi Y, Clausen BE et al (2003) HIF-1alpha Is Essential for Myeloid Cell-Mediated Inflammation. Cell 112:645-657
7. Distler J, Hirth A, Kurowska M, Gay RE, Gay S, Distler O (2003) Angiogenic and angiostatic factors in the molecular control of angiogenesis. QJ Nucl Med 47:149-161
8. Kim JM, Ho SH, Park EJ et al (2002) Angiostatin gene transfer as an effective treatment strategy in murine collagen-induced arthritis. Arthritis Rheum 46:793-801
9. Distler O, Neidhart M, Gay RE, Gay S (2002) The molecular control of angiogenesis. Int Rev Immunol 21:33-49
10. Distler O, Pap T, Kowal-Bielecka O et al (2001) Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis. Arthritis Rheum 44:2665-2678
11. Distler O, del Rosso A, Giacomelli R et al (2002) Angiogenic and angiostatic factors in systemic sclerosis: Increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res 4:R11
12. Dor Y, Djonov V, Abramovitch R et al (2002) Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J 21:1939-1947